Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3115)
All Articles published online
|
Oct 14, 2005 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shen HW, Gao SL, Wu YL, Peng SY. Overexpression of decoy receptor 3 in hepatocellular carcinoma and its association with resistance to Fas ligand-mediated apoptosis. World J Gastroenterol 2005; 11(38): 5926-5930 [PMID: 16273601 DOI: 10.3748/wjg.v11.i38.5926] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i38/5926.htm |
| Number | Citing Articles |
| 1 |
Chunlan Li, Shanshan Chen, Jinyun Song, Hongyan Liu, Wei Gu, Hongxin Ai, Bo Zhao, Shuangquan Zhang. Molecular cloning and characterization of TNFSF14 (LIGHT) and its receptor TNFRSF14 (HVEM) in guinea pig (Cavia porcellus). Gene 2013; 526(2): 374 doi: 10.1016/j.gene.2013.05.031
|
| 2 |
CR Yang, JH Guh, CM Teng, CC Chen, PH Chen. Combined treatment with Denbinobin and Fas ligand has a synergistic cytotoxic effect in human pancreatic adenocarcinoma BxPC‐3 cells. British Journal of Pharmacology 2009; 157(7): 1175 doi: 10.1111/j.1476-5381.2009.00237.x
|
| 3 |
Jian Zhou, Shi-Duo Song, De-Chun Li, Jin Zhou, Dong-Ming Zhu, Shi-Ying Zheng. Clinical Significance of Expression and Amplification of the DcR3 Gene in Pancreatic Carcinomas. Asian Pacific Journal of Cancer Prevention 2012; 13(2): 719 doi: 10.7314/APJCP.2012.13.2.719
|
| 4 |
Pei-Hsuan Chen, Chia-Ron Yang. Decoy Receptor 3 Expression in AsPC-1 Human Pancreatic Adenocarcinoma Cells via the Phosphatidylinositol 3-Kinase-, Akt-, and NF-κB-Dependent Pathway. The Journal of Immunology 2008; 181(12): 8441 doi: 10.4049/jimmunol.181.12.8441
|
| 5 |
Cheng-Hsun Ho, Chen-Fang Hsu, Pei-Fen Fong, Shyh-Kuan Tai, Shie-Liang Hsieh, Chi-Ju Chen. Epstein-Barr Virus Transcription Activator Rta Upregulates Decoy Receptor 3 Expression by Binding to Its Promoter. Journal of Virology 2007; 81(9): 4837 doi: 10.1128/JVI.02448-06
|
| 6 |
Wan-Wan Lin, Shie-Liang Hsieh. Decoy receptor 3: A pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer. Biochemical Pharmacology 2011; 81(7): 838 doi: 10.1016/j.bcp.2011.01.011
|
| 7 |
Jintaek Im, Kyutae Kim, Polla Hergert, Richard Seonghun Nho. Idiopathic pulmonary fibrosis fibroblasts become resistant to Fas ligand‐dependent apoptosis via the alteration of decoy receptor 3. The Journal of Pathology 2016; 240(1): 25 doi: 10.1002/path.4749
|
| 8 |
S. Kim, V. Kotoula, P. Hytiroglou, D. Zardavas, L. Zhang. Significance of increased expression of decoy receptor 3 in chronic liver disease. Digestive and Liver Disease 2009; 41(8): 591 doi: 10.1016/j.dld.2008.11.019
|
| 9 |
Xiao-Na Zhou, Guang-Ming Li, Ying-Chen Xu, Tuan-Jie Zhao, Ji-Xiang Wu. Knockdown of Decoy Receptor 3 Impairs Growth and Invasiveness of Hepatocellular Carcinoma Cell Line of HepG2. Chinese Medical Journal 2016; 129(21): 2623 doi: 10.4103/0366-6999.192775
|
| 10 |
Marcos W. Steinberg, Timothy C. Cheung, Carl F. Ware. The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation. Immunological Reviews 2011; 244(1): 169 doi: 10.1111/j.1600-065X.2011.01064.x
|
| 11 |
Yan-Ping Liu, Hui-Fang Zhu, Ding-li Liu, Zhi-Yan Hu, Sheng-Nan Li, He-Ping Kan, Xiao-Yan Wang, Zu-Guo Li. DcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRC. Oncotarget 2016; 7(47): 77306 doi: 10.18632/oncotarget.12639
|
| 12 |
Timothy C. Cheung, Ken Coppieters, Hideki Sanjo, Lisa M. Oborne, Paula S. Norris, Amy Coddington, Steven W. Granger, Dirk Elewaut, Carl F. Ware. Polymorphic Variants of LIGHT (TNF Superfamily-14) Alter Receptor Avidity and Bioavailability. The Journal of Immunology 2010; 185(3): 1949 doi: 10.4049/jimmunol.1001159
|
| 13 |
Hsi‐Feng Tu, Chung‐Ji Liu, Shyun‐Yeu Liu, Yu‐Ping Chen, En‐Hao Yu, Shu‐Chun Lin, Kuo‐Wei Chang. Serum decoy receptor 3 level: A predictive marker for nodal metastasis and survival among oral cavity cancer patients. Head & Neck 2011; 33(3): 396 doi: 10.1002/hed.21467
|
| 14 |
Joseph P. Connor, Mildred Felder. Ascites from epithelial ovarian cancer contain high levels of functional decoy receptor 3 (DcR3) and is associated with platinum resistance. Gynecologic Oncology 2008; 111(2): 330 doi: 10.1016/j.ygyno.2008.07.012
|
| 15 |
Tuanjie Zhao, Yingchen Xu, Shulin Ren, Chaojie Liang, Xiaona Zhou, Jixiang Wu. The siRNA silencing of DcR3 expression induces Fas ligand-mediated apoptosis in HepG2 cells. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.5964
|
| 16 |
ZHICHENG GE, ANDREW J. SANDERS, LIN YE, WEN G. JIANG. Aberrant expression and function of death receptor-3 and death decoy receptor-3 in human cancer. Experimental and Therapeutic Medicine 2011; 2(2): 167 doi: 10.3892/etm.2011.206
|
| 17 |
Stephan Macher-Goeppinger, Sebastian Aulmann, Nina Wagener, Benjamin Funke, Katrin E. Tagscherer, Axel Haferkamp, Markus Hohenfellner, Sunghee Kim, Frank Autschbach, Peter Schirmacher, Wilfried Roth. Decoy Receptor 3 Is a Prognostic Factor in Renal Cell Cancer. Neoplasia 2008; 10(10): 1049 doi: 10.1593/neo.08626
|
| 18 |
Joseph P Connor, Mildred Felder, Arvinder Kapur, Nonyem Onujiogu. DcR3 binds to ovarian cancer via heparan sulfate proteoglycans and modulates tumor cells response to platinum with corresponding alteration in the expression of BRCA1. BMC Cancer 2012; 12(1) doi: 10.1186/1471-2407-12-176
|
| 19 |
Gang Chen, Minhua Rong, Dianzhong Luo. TNFRSF6B neutralization antibody inhibits proliferation and induces apoptosis in hepatocellular carcinoma cell. Pathology - Research and Practice 2010; 206(9): 631 doi: 10.1016/j.prp.2010.05.011
|
| 20 |
Cheng-Hsun Ho, Chi-Long Chen, Wing-Yin Li, Chi-Ju Chen. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion. Carcinogenesis 2009; 30(8): 1443 doi: 10.1093/carcin/bgp135
|
| 21 |
S Colucci, G Brunetti, G Mori, A Oranger, M Centonze, C Mori, F P Cantatore, R Tamma, R Rizzi, V Liso, A Zallone, M Grano. Soluble decoy receptor 3 modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients. Leukemia 2009; 23(11): 2139 doi: 10.1038/leu.2009.136
|
| 22 |
Meisongzhu Yang, Gang Chen, Yiwu Dang, Dianzhong Luo. Significance of decoy receptor 3 in sera of hepatocellular carcinoma patients. Upsala Journal of Medical Sciences 2010; 115(4): 232 doi: 10.3109/03009734.2010.516410
|
| 23 |
Giorgos Bamias, Michalis Gizis, Ioanna Delladetsima, Eyfrosyni Laoudi, Spyros I. Siakavellas, Ioannis Koutsounas, Garyfallia Kaltsa, John Vlachogiannakos, Irene Vafiadis-Zouboulis, George L. Daikos, George V. Papatheodoridis, Spiros D. Ladas. Elevated Serum Levels of the Antiapoptotic Protein Decoy-Receptor 3 Are Associated with Advanced Liver Disease. Canadian Journal of Gastroenterology and Hepatology 2016; 2016: 1 doi: 10.1155/2016/2637010
|